Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
AILERON THERAPTS RG (NQ: ALRN)
5.020 USD  UNCHANGED
Official Closing Price  /  Updated: 8:00 PM EDT, Jul 13, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 29,448
Open 4.950
Bid (Size) 4.050 (100)
Ask (Size) 5.500 (500)
Prev. Close 5.020
Today's Range 4.850 - 5.050
52wk Range 4.840 - 15.48
Shares Outstanding 14,737,402
Dividend Yield N/A
Performance
YTD
-52.28%
-52.28%
1 Month
-6.17%
-6.17%
3 Month
-27.87%
-27.87%
6 Month
-46.54%
-46.54%
1 Year
-61.24%
-61.24%
Top News
More News
Aileron Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
Aileron Therapeutics (Nasdaq:ALRN), the leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced that Manuel Aivado, CMO and CSO, will present at the... Read More
from GlobeNewswire News Releases
Aileron Therapeutics Announces Publication of ALRN-6924 Nonclinical Data in T-cell Lymphomas by Researchers at Dana-Farber Cancer Institute
Data published in Nature Communications show MDM2 and MDMX are targetable vulnerabilities within TP53-wild-type T-cell Lymphomas Read More
from GlobeNewswire News Releases
More News
Read More
Aileron Therapeutics Announces Changes to Management
from GlobeNewswire News Releases
Aileron Therapeutics Reports First Quarter 2018 Financial Results
from GlobeNewswire News Releases
Aileron Therapeutics Announces Publication by Researchers at Albert Einstein College of Medicine of ALRN-6924 Nonclinical Data in Acute Myeloid Leukemia
from GlobeNewswire News Releases
Aileron Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
from GlobeNewswire News Releases
Aileron Therapeutics Announces Expansion of Scientific Advisory Board
from GlobeNewswire News Releases
Aileron Therapeutics Appoints Jeffrey A. Bailey to its Board of Directors
from GlobeNewswire News Releases
Analysts Anticipate IWV To Hit $178
category ETFs
from ETF Channel
BRIEF-Aileron Therapeutics Appoints Jeffrey Bailey As Chairman Of Board
category companyNews
from Reuters: Company News
Oversold Conditions For Aileron Therapeutics (ALRN)
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.